Opening Bell: Citigroup, Goldman Sachs, United Health, Walgreens, Trump Media, United Therapeutics
Der Rekordlauf an der Wall Street setzte sich auch zu Wochenbeginn fort. Erneut erklommen Dow Jones und S&P 500 neue…
484,100€
-0,88%
Echtzeit-Aktienkurs United Therapeutics Corp
Bid:
Ask:
Nachrichten zur United Therapeutics Corp Aktie
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative…
Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think "Yes"
United Therapeutics (UTHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.…
Liquidia surges after United Therapeutics request for preliminary injunction denied (update)
…
Earnings call: United Therapeutics reports strong Q1 with record revenue By Investing.com
Earnings call: United Therapeutics reports strong Q1 with record revenue…
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
United Therapeutics (UTHR) first-quarter 2024 earnings and sales beat estimates. Tyvaso sales continue to drive the companys top line.…
United Therapeutics motion for restraining order over Liquidias Yutrepia denied
…
United Therapeutics CEO sells over $7 million in company stock By Investing.com
United Therapeutics CEO sells over $7 million in company stock…
United Therapeutics initiates $1 billion stock buyback By Investing.com
United Therapeutics initiates $1 billion stock buyback…
United Therapeutics: Neutral Stance On Tyvasos Patent Challenges And Future Growth Prospects
…
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and…